Table 3.
Items | Remarks | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Treatment allocation | Blinding | Loss to follow-up |
Total score |
||||||||||
Study | Eligibility criteria |
Randomized | Concealed allocation |
Baseline comparability |
Subjects | Therapists | Assessors | Measures obtained in 85% of all initially included subjects | Intention to treat | Group comparison reported |
Point measures and measures of variability reported |
||
van Brussel et al., (2008) [73] |
Yes | Yes | Yes | Yes1 | No | No | Yes | Yes | Yes | Yes | Yes | 8/10 | 1Corrections were applied |
| |||||||||||||
Mintz-Itkin et al., (2009) [61] |
Yes | No2 | No2 | Yes | No | No | No | No3 | No | Yes | Yes | 3/10 |
2No randomization method was specified 3No data on loss to follow-up was presented |
| |||||||||||||
Kemp et al., (2009) [59] |
Yes | Yes | Yes | Yes4 | No | No3 | No | No | Yes | Yes | Yes | 6/10 |
3Therapists were blinded for disease characteristics 4No formal statistical data was presented in which baseline comparability was ascertained |